BioSpace News Archive

Drug Development

CEL-SCI Reports Recent Data Review By the Independent Data Monitoring Committee for Its Pivotal Phase III Head and Neck Cancer Study

CEL-SCI Corporation announced today that the Independent Data Monitoring Committee (IDMC) for the Company’s pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) has completed its review of the Phase 3 study data.

December 7, 2017

·

3 min read

TearLab Tweaks Regulatory Strategy for Next-Genera

BioMidwest

5 Smaller Biotechs That are Flying Under-the-Radar

These companies are important to follow as they have exponential growth potential and are working on new and innovative drugs.

December 7, 2017

·

7 min read

Biotech Beach

Thermo Fisher: New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

Thermo Fisher Scientific’s Ion Torrent Oncomine Myeloid Research Assay interrogates DNA mutations, RNA fusion transcripts and gene expression levels associated with myeloid cancers in a single run, yielding results in 2-3 days.

December 7, 2017

·

4 min read

Deals

Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer

The Offer will expire at 12:00 midnight, New York City time, on January 19, 2018, unless extended (the latest time and date at which the Offer will expire, the “Expiration Date”).

December 7, 2017

·

9 min read

Orthocell Commences Treatment of its 1,000th Patient

This marks a significant milestone in the Company’s history as it continues to clinically validate its market leading regenerative medicine technologies and drive entry into the US, the world’s largest healthcare market.

December 7, 2017

·

4 min read

Expert Review Panel for Diagnostics Approves Atomo HIV Self Test for Procurement by Unitaid and the Global Fund

Following on from its recent CE Mark approval, which enables Atomo to market the product in Europe, the ERP-D approval will facilitate further expansion and commercial roll-out of the product in LMICs.

December 7, 2017

·

2 min read

Business

WishBone Medical Names Jean-Pierre Capdevielle as Chief Strategy Officer and Board Member

Mr. Capdevielle is a seasoned executive with over 37 years of international experience and has a successful track record of helping startup companies.

December 7, 2017

·

3 min read

Drug Development

Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) in Patients With Relapsed or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC)

The independent centrally-reviewed (ICR) median DOR was 9.1 months. These efficacy data are summarized in the table below.

December 7, 2017

·

6 min read

Bio NC

G1 Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The inducement grant to Mr. Phillips consisted of an option to purchase up to 150,000 shares of common stock.

December 7, 2017

·

3 min read

GW Pharmaceuticals Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $276M

Closing of the offering is expected to occur on 11 December, 2017.

December 7, 2017

·

5 min read